Slow-flow malformation, venous type

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:211252
Who is this for?
Show terms as
3Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Slow-flow malformation, venous type (also known as venous malformation or VM) is a congenital vascular anomaly characterized by abnormally formed veins that create dilated, sponge-like channels filled with slow-moving blood. These malformations are present at birth, although they may not become clinically apparent until later in life. They can occur anywhere in the body but most commonly affect the skin, subcutaneous tissues, muscles, and mucous membranes (such as the oral cavity). Venous malformations tend to grow proportionally with the individual and may expand over time, particularly during puberty, pregnancy, or following trauma. Key clinical features include soft, compressible, blue-purple masses that swell with dependent positioning or Valsalva maneuver. Patients may experience pain, swelling, and functional impairment depending on the location and size of the malformation. Localized intravascular coagulopathy (LIC) is a common complication, characterized by elevated D-dimer levels and low fibrinogen, which can occasionally progress to disseminated intravascular coagulation (DIC). Phleboliths (calcified thrombi) are frequently found within the lesion and are a hallmark radiographic finding. Joint involvement can lead to arthropathy and limited range of motion. Most venous malformations occur sporadically, though familial forms exist, including those associated with somatic or germline mutations in the TEK (TIE2) gene or PIK3CA gene. Treatment is multidisciplinary and may include compression garments, low-molecular-weight heparin for coagulopathy management, sclerotherapy (injection of sclerosing agents to shrink the malformation), surgical resection, and in some cases sirolimus (an mTOR inhibitor) for extensive or symptomatic lesions. Complete cure is often difficult to achieve, and management focuses on symptom control and prevention of complications. Diagnosis is typically confirmed through MRI, which shows characteristic T2-hyperintense lesions with slow flow.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Slow-flow malformation, venous type.

View clinical trials →

No actively recruiting trials found for Slow-flow malformation, venous type at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Slow-flow malformation, venous type community →

Specialists

3 foundView all specialists →
LF
Lydia Pathmanathan, MBBS, FRACP.
Specialist
PI on 1 active trial
SF
Stephen Luen, MBChB, FRACP.
Specialist
PI on 1 active trial
TF
Tony Penington, MBBS, FRACS.
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Slow-flow malformation, venous type.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Slow-flow malformation, venous typeForum →

No community posts yet. Be the first to share your experience with Slow-flow malformation, venous type.

Start the conversation →

Latest news about Slow-flow malformation, venous type

No recent news articles for Slow-flow malformation, venous type.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Slow-flow malformation, venous type

What is Slow-flow malformation, venous type?

Slow-flow malformation, venous type (also known as venous malformation or VM) is a congenital vascular anomaly characterized by abnormally formed veins that create dilated, sponge-like channels filled with slow-moving blood. These malformations are present at birth, although they may not become clinically apparent until later in life. They can occur anywhere in the body but most commonly affect the skin, subcutaneous tissues, muscles, and mucous membranes (such as the oral cavity). Venous malformations tend to grow proportionally with the individual and may expand over time, particularly durin

How is Slow-flow malformation, venous type inherited?

Slow-flow malformation, venous type follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Slow-flow malformation, venous type typically begin?

Typical onset of Slow-flow malformation, venous type is neonatal. Age of onset can vary across affected individuals.

Which specialists treat Slow-flow malformation, venous type?

3 specialists and care centers treating Slow-flow malformation, venous type are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.